All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Derivatives

Derivatives Reform May Not Mean Greater OTC Transparency

New derivatives regulation aimed at making the market more transparent may not accomplish its goal, according to Craig Donohue, ceo of CME Group.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree